Journal article
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement
Annals of internal medicine, Vol.161(11), pp.819-826
12/02/2014
DOI: 10.7326/M14-1884
PMID: 25200125
Abstract
Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy.
The USPSTF reviewed the evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in women at increased risk and in decreasing adverse maternal and perinatal health outcomes, and assessed the maternal and fetal harms of low-dose aspirin during pregnancy.
This recommendation applies to asymptomatic pregnant women who are at increased risk for preeclampsia and who have no prior adverse effects with or contraindications to low-dose aspirin.
The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. (B recommendation).
Details
- Title: Subtitle
- Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement
- Creators
- Michael L LeFevreU.S. Preventive Services Task Force
- Contributors
- Sue J Curry (Contributor) - University of Iowa, Community and Behavioral Health
- Resource Type
- Journal article
- Publication Details
- Annals of internal medicine, Vol.161(11), pp.819-826
- DOI
- 10.7326/M14-1884
- PMID
- 25200125
- NLM abbreviation
- Ann Intern Med
- ISSN
- 0003-4819
- eISSN
- 1539-3704
- Publisher
- United States
- Language
- English
- Date published
- 12/02/2014
- Academic Unit
- Health Management and Policy; Community and Behavioral Health
- Record Identifier
- 9984063206602771
Metrics
23 Record Views